Key Takeaways
- • AcuityMD closed an $80 million Series C funding round led by existing investor StepStone Group, with participation from Benchmark, Redpoint Ventures, ICONIQ, and Atreides Management, bringing total funding to over $160 million.
- • The company is valued at $955 million post-funding and was named to Forbes' 2025 "Next Billion-Dollar Startups" list, positioning it as a near-unicorn within the MedTech intelligence sector.
- • AcuityMD serves 16 of the top 20 MedTech companies globally and has helped customers identify over $34 billion in commercial pipeline opportunities, demonstrating strong market adoption among enterprise buyers.
- • The platform combines proprietary MedTech ontology, real-world healthcare data, and AI-powered analytics to unify fragmented intelligence across claims databases, FDA filings, physician networks, and regulatory signals into a single operational layer for commercial teams.
- • The capital infusion will accelerate development of AcuityAI, the company's AI-driven analytics engine currently in open beta, designed to reduce manual research dependencies and enable faster market identification and opportunity targeting.
Summary
AcuityMD, an AI platform serving the medical technology sector, announced an $80 million Series C funding round on April 21, 2026. The round was led by StepStone Group, an existing investor, with additional participation from venture capital firms Benchmark, Redpoint Ventures, ICONIQ, and Atreides Management. This raise brings AcuityMD's total funding to over $160 million and establishes the company's valuation at $955 million, placing it within striking distance of unicorn status. The company was recently recognized on Forbes' 2025 "Next Billion-Dollar Startups" list, identifying it as among 25 venture-backed U.S. companies most likely to reach $1 billion in valuation.
The platform has achieved substantial market penetration within the MedTech sector, currently serving over 400 MedTech companies, including 16 of the top 20 by scale. This customer concentration among tier-one firms underscores the platform's strategic importance to the industry. AcuityMD's commercial impact is quantified by the $34 billion in pipeline opportunities its users have identified, reflecting the substantial value its intelligence layer delivers to customers evaluating market entry, expansion, and resource allocation decisions.
AcuityMD's core offering centers on a proprietary MedTech ontology that structures healthcare data at enterprise scale. The system aggregates and standardizes data from fragmented sources including claims databases, FDA filings, government records, and physician networks, then unifies this external intelligence with internal company systems such as CRM platforms and territory structures. This creates an integrated operational intelligence layer that consolidates information previously scattered across disconnected tools.
The funding will accelerate development of AcuityAI, the company's AI-driven analytics engine currently in open beta. This layer combines real-time market data with company-specific context and user roles, enabling commercial teams to generate targeted insights without manual research across multiple platforms. Investors highlighted the strategic importance of structured healthcare data infrastructure as artificial intelligence adoption accelerates across the MedTech sector, positioning AcuityMD's dataset as increasingly valuable in the evolving AI landscape.
The platform has achieved substantial market penetration within the MedTech sector, currently serving over 400 MedTech companies, including 16 of the top 20 by scale. This customer concentration among tier-one firms underscores the platform's strategic importance to the industry. AcuityMD's commercial impact is quantified by the $34 billion in pipeline opportunities its users have identified, reflecting the substantial value its intelligence layer delivers to customers evaluating market entry, expansion, and resource allocation decisions.
AcuityMD's core offering centers on a proprietary MedTech ontology that structures healthcare data at enterprise scale. The system aggregates and standardizes data from fragmented sources including claims databases, FDA filings, government records, and physician networks, then unifies this external intelligence with internal company systems such as CRM platforms and territory structures. This creates an integrated operational intelligence layer that consolidates information previously scattered across disconnected tools.
The funding will accelerate development of AcuityAI, the company's AI-driven analytics engine currently in open beta. This layer combines real-time market data with company-specific context and user roles, enabling commercial teams to generate targeted insights without manual research across multiple platforms. Investors highlighted the strategic importance of structured healthcare data infrastructure as artificial intelligence adoption accelerates across the MedTech sector, positioning AcuityMD's dataset as increasingly valuable in the evolving AI landscape.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.